Yu-Mei Shi, Gongyan Chen, Xiang Wang, Yunpeng Liu, Lin Wu, Yanrong Hao, Chunling Liu, Shuyang Zhu, Xiaodong Zhang, Yuping Li, Jiwei Liu, Lejie Cao, Ying Cheng, Hui-fang Zhao, Shucai Zhang, A. Zang, J. Cui, Jian Feng, N. Yang, Fei Liu, Yong Jiang, Chuan Gu
求助PDF
{"title":"Furmonertinib (AST2818) versus gefitinib as first-line therapy for Chinese patients with locally advanced or metastatic EGFR mutation-positive non-small-cell lung cancer (FURLONG): a multicentre, double-blind, randomised phase 3 study.","authors":"Yu-Mei Shi, Gongyan Chen, Xiang Wang, Yunpeng Liu, Lin Wu, Yanrong Hao, Chunling Liu, Shuyang Zhu, Xiaodong Zhang, Yuping Li, Jiwei Liu, Lejie Cao, Ying Cheng, Hui-fang Zhao, Shucai Zhang, A. Zang, J. Cui, Jian Feng, N. Yang, Fei Liu, Yong Jiang, Chuan Gu","doi":"10.1016/s2213-2600(22)00168-0","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":326030,"journal":{"name":"The Lancet. Respiratory medicine","volume":"20 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"35","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Lancet. Respiratory medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/s2213-2600(22)00168-0","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 35
引用
批量引用
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
